(Q31008861)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

J Carlsson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Z P Ren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

K Wester

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A L Sundberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

N E Heldin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Hesselager

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Persson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

L Gedda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

H Lundqvist

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

E Blomquist

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Nistér

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

33-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16200342%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-005-7410-z

7 January 2020

exact match

0 references

cites work

Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-7410-Z

A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-7410-Z

Binding, internalization and excretion of TGF alpha-dextran associated radioactivity in cultured human glioma cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-7410-Z

Survival and functional status after resection of recurrent glioblastoma multiforme.

21 January 2018

1 reference

12 December 2020

Cell signaling by receptor tyrosine kinases

1 reference

12 December 2020

Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation

1 reference

12 December 2020

Classification of glioblastoma multiforme in adults by molecular genetics

1 reference

12 December 2020

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

1 reference

12 December 2020

Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier

1 reference

12 December 2020

Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture

1 reference

12 December 2020

Targeted therapy of cancer with radiolabeled antibodies

1 reference

12 December 2020

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme

1 reference

12 December 2020

Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase.

1 reference

12 December 2020

"...those left behind." Biology and oncology of invasive glioma cells

1 reference

12 December 2020

Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.

1 reference

12 December 2020

New approaches in targeting intracerebral tumours with 90Y-labelled radiopeptides

1 reference

12 December 2020

Comparing monoclonal antibodies and small peptidic hormones for local targeting of malignant gliomas

1 reference

12 December 2020

The solution structures of epidermal growth factor and transforming growth factor alpha

1 reference

12 December 2020

Advancements in cancer therapy with alpha-emitters: a review

1 reference

12 December 2020

Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.

1 reference

12 December 2020

Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran

1 reference

12 December 2020

Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor

1 reference

12 December 2020

Lymphoscintigraphy with 13I-labelled epidermal growth factor

1 reference

12 December 2020

Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice

1 reference

12 December 2020

Uptake of a boronated epidermal growth factor-dextran conjugate in CHO xenografts with and without human EGF-receptor expression.

1 reference

12 December 2020

Development of novel targeted therapies in the treatment of malignant glioma

1 reference

12 December 2020

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

12 December 2020

EGF and dextran-conjugated EGF induces differential phosphorylation of the EGF receptor

1 reference

12 December 2020

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

1 reference

12 December 2020

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

12 December 2020

Intratumoral delivery of boronated epidermal growth factor for neutron capture therapy of brain tumors.

1 reference

12 December 2020

Influence of Chloroquine and Lidocaine on Retention and Cytotoxic Effects of [131I]EGF: Studies on Cultured Glioma Cells

1 reference

12 December 2020

Cancer therapy with Auger electrons: are we almost there?

1 reference

12 December 2020

Cellular processing of (125)I- and (111)in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells

1 reference

12 December 2020

Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancer

1 reference

12 December 2020

A polymerase chain reaction-based assay for the rapid detection of gene amplification in human tumors

1 reference

12 December 2020

EGF mutant receptor vIII as a molecular target in cancer therapy

1 reference

12 December 2020

Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma

1 reference

12 December 2020

Strategy for planned radiotherapy of malignant gliomas: Postoperative treatment with combinations of high dose proton irradiation and tumor seeking radionuclides

1 reference

12 December 2020

Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic results

1 reference

12 December 2020

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 reference

12 December 2020

Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells

1 reference

12 December 2020

Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity

1 reference

12 December 2020

A new antibody recognizing the vIII mutation of human epidermal growth factor receptor

1 reference

12 December 2020

Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats.

1 reference

12 December 2020

Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors

1 reference

12 December 2020

Phenotype vs genotype in the evolution of astrocytic brain tumors

1 reference

12 December 2020

111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.

1 reference

12 December 2020

Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.

1 reference

12 December 2020

[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.

1 reference

12 December 2020

Biodistribution of 111In-labelled SCN-bz-DTPA-BC-2 MAb following loco-regional injection into glioblastomas.

1 reference

12 December 2020

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

1 reference

12 December 2020

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

1 reference

12 December 2020

Expression of epidermal growth factor receptor in urinary bladder cancer metastases

1 reference

12 December 2020

Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF

1 reference

12 December 2020

Conjugate chemistry, iodination and cellular binding of mEGF-dextran-tyrosine: preclinical tests in preparation for clinical trials.

1 reference

12 December 2020

A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.

1 reference

12 December 2020

Tumour therapy with radionuclides: assessment of progress and problems.

1 reference

12 December 2020

Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach

1 reference

12 December 2020

HER-2--a possible target for therapy of metastatic urinary bladder carcinoma

1 reference

12 December 2020

Monoclonal antibodies for brain tumour treatment

1 reference

12 December 2020

Penetration and binding of epidermal growth factor-dextran conjugates in spheroids of human glioma origin

1 reference

12 December 2020

Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.

1 reference

12 December 2020

Radioiodinated (I-125) monoclonal antibody 425 in the treatment of high grade glioma patients: ten-year synopsis of a novel treatment.

1 reference

12 December 2020

A kit formulated under good manufacturing practices for labeling human epidermal growth factor with 111In for radiotherapeutic applications.

1 reference

12 December 2020

Advancing role of radiolabeled antibodies in the therapy of cancer

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides

1 reference

12 December 2020

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

1 reference

12 December 2020

Radionuclide-antibody conjugates for single-cell cytotoxicity

1 reference

12 December 2020

Distribution and stability in the rat of a 76Br/125I-labelled polypeptide, epidermal growth factor.

1 reference

12 December 2020

Peptide receptor radionuclide therapy

1 reference

12 December 2020

Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.

1 reference

12 December 2020

Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy

1 reference

12 December 2020

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study

1 reference

12 December 2020

Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas

1 reference

12 December 2020

Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times.

1 reference

12 December 2020

Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.

1 reference

12 December 2020

Intracavitary Chemotherapy for Glioblastoma: Present Status and Future Directions

1 reference

12 December 2020

Technology evaluation: ABX-EGF, Abgenix/Amgen

1 reference

12 December 2020

Prognostic applications of the epidermal growth factor receptor and its ligand, transforming growth factor-alpha.

1 reference

12 December 2020

Epidermal growth factor receptor tyrosine kinase inhibitors: evolving role in the treatment of solid tumors

1 reference

12 December 2020

Targeted radiotherapy of brain tumours

1 reference

12 December 2020

Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment

1 reference

12 December 2020

Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.

1 reference

12 December 2020

The molecular biology of cancer

1 reference

12 December 2020

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF.

1 reference

12 December 2020

Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy

1 reference

12 December 2020

Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues

1 reference

12 December 2020

Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies

1 reference

12 December 2020

Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide

1 reference

12 December 2020

EGF receptor in neoplasia and metastasis

1 reference

12 December 2020

Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies

1 reference

12 December 2020

111InBz-DTPA-hEGF: Preparation andIn VitroCharacterization of a Potential Anti-Glioblastoma Targeting Agent

1 reference

12 December 2020

Targeted radiotherapy using Auger electron emitters

1 reference

12 December 2020

Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies.

1 reference

12 December 2020

Gefitinib--a novel targeted approach to treating cancer

1 reference

12 December 2020

Primary and secondary glioblastomas: from concept to clinical diagnosis

1 reference

12 December 2020

Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor.

1 reference

12 December 2020

Penetration of etoposide into human malignant brain tumors after intravenous and oral administration

1 reference

12 December 2020

Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.

1 reference

12 December 2020

Migration and invasion in brain neoplasms

1 reference

12 December 2020

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

1 reference

12 December 2020

Effects of 131I-EGF on cultured human glioma cells

1 reference

12 December 2020

Targeted drug delivery for brain cancer treatment

1 reference

12 December 2020

Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.

1 reference

12 December 2020

The EGFR as a target for anticancer therapy--focus on cetuximab

1 reference

12 December 2020

Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.

1 reference

12 December 2020

Current status of therapy of solid tumors: brain tumor therapy.

1 reference

12 December 2020

Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.

1 reference

12 December 2020

Cellular localisation of human epidermal growth factor receptor

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo.

1 reference

12 December 2020

Technetium-99m labeled epidermal growth factor-tumor imaging in mice.

1 reference

12 December 2020

Conjugate chemistry and cellular processing of EGF-dextran

1 reference

12 December 2020

Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues

1 reference

12 December 2020

High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules

1 reference

12 December 2020